OssDsign

    OverviewSuggest Edit

    OssDsign is a medtech company dedicated to creating regenerative implants for improved healing of bone defects. The company provides neurosurgeons and reconstructive plastic surgeons with a range of implant solutions. Its products include OSSDSIGN Cranial, an implant solution for cranioplasty patients; OSSDSIGN Facial to treat complex facial skeletal defects; and OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage.
    TypePublic
    Founded2011
    HQUppsala, SE
    Websiteossdsign.com

    Latest Updates

    Employees (est.) (Feb 2020)40
    Cybersecurity ratingBMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at OssDsign

    Anders Qvarnström

    Anders Qvarnström

    Director
    Simon Cartmell

    Simon Cartmell

    Director and Chairman
    Morten Henneveld

    Morten Henneveld

    CEO
    Newton Aguiar

    Newton Aguiar

    Director
    Viktor Drvota

    Viktor Drvota

    Director
    Kajsa Björklund

    Kajsa Björklund

    Director Technical Operations
    Show more

    OssDsign Office Locations

    OssDsign has an office in Uppsala
    Uppsala, SE (HQ)
    Uppsala Business Park Rapsgatan 7 Postal Address:, Virdings allé 2
    Uppsala, SE
    Rapsgatan 23
    Show all (2)

    OssDsign Online and Social Media Presence

    Embed Graph

    OssDsign News and Updates

    Karolinska Development's portfolio company OssDsign receives expanded FDA market clearance for OssDsign Cranial PSI

    STOCKHOLM, SWEDEN, 4 October 2021 Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign AB has received an expanded marketing authorization from the U.S. Food and Drug Administration (FDA) for the company's patient-specific cranial implant product Oss…

    Karolinska Development's portfolio company OssDsign includes first patient to a clinical trial of the synthetic bone graft OssDsign Catalyst

    STOCKHOLM, SWEDEN – September 9, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company OssDsign AB has included the first patient to the clinical trial TOP FUSION which aims to evaluate the long-term safety and efficacy of the synthetic bone graft OssDsi…

    Karolinska Development's portfolio company OssDsign launches the synthetic bone graft OssDsign Catalyst on the U.S. market

    STOCKHOLM, SWEDEN – August 16, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company OssDsign AB has launched OssDsign Catalyst in the U.S. The product is a synthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surger…

    OssDsign Partners with Red One Medical to Provide Reconstructive Cranial Solutions and Synthetic Bone Grafts to US Veterans and Military Members

    SAVANNAH, Ga., Aug. 10, 2021 /PRNewswire/ -- OssDsign, a global provider of reconstructive implant solutions, has recently entered into an agreement with Red One Medical, a private sector scout of medical innovation for the Department of Veterans Affairs (VA) and Department of Defense...

    Prestigious publication confirms potential of technology used by Karolinska Development's portfolio company OssDsign

    STOCKHOLM, SWEDEN – October 14, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that a scientific article describing the portfolio company OssDsign's unique regenerative implants has been published in the reputable scientific journal PNAS (Proceedings of the National Academy…

    Karolinska Development’s portfolio company OssDsign strengthens patent coverage for OssDsign Cranial PSI in key market

    STOCKHOLM, SWEDEN – September 18, 2020. Karolinska Development (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has received a notice of allowance from the United States Patent and Trademarks Office (USPTO) concerning the implant design for the company’s product Cranial PSI, th…
    Show more

    OssDsign Frequently Asked Questions

    • When was OssDsign founded?

      OssDsign was founded in 2011.

    • Who are OssDsign key executives?

      OssDsign's key executives are Anders Qvarnström, Simon Cartmell and Morten Henneveld.

    • How many employees does OssDsign have?

      OssDsign has 40 employees.

    • Who are OssDsign competitors?

      Competitors of OssDsign include Graftys, Abyrx and Stroke2Prevent.

    • Where is OssDsign headquarters?

      OssDsign headquarters is located at Uppsala Business Park Rapsgatan 7 Postal Address:, Virdings allé 2, Uppsala.

    • Where are OssDsign offices?

      OssDsign has an office in Uppsala.

    • How many offices does OssDsign have?

      OssDsign has 2 offices.